Taking Wegovy can increase the risk of serious medical conditions such as acute pancreatitis, gallbladder disease, kidney injury, increased heart rate, low blood sugar, and mental health changes
Strategies to reduce the issue: Take with food (for oral formulations) Follow administration with a beverage Consider alternative delivery formats (injection, topical) if taste is bothersome Time doses to minimize coincidence with meals where possible Other Safety Considerations Pregnancy and lactation
Molecular Properties BPC-157 is notable for several physicochemical properties that make it attractive as a research tool: Stability in acidic conditions unlike most peptides, BPC-157 is stable in gastric juice (pH 1-2) without degradation Water solubility highly soluble in aqueous solutions, making reconstitution straightforward No known toxicity in published rodent studies at standard research doses Resistance to enzymatic degradation more stable than typical peptides of similar length Published Research Areas The following areas represent the bulk of published BPC-157 research
If you are running a triple-agonist program, evaluating one to license in, building a competitive follow-on, or deciding whether to spend $50M on a Paragraph IV challenge five years from now, the IP structure in this space is the single largest variable in your outcome
For the study, they surveyed current, previous and potential consumers of GLP-1s to better understand how taking these medications affects food choices
